The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 139-144

  Haarbo, Jens ^a   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

17 estradiol; Atherogenesis; Levonorgestrel; Lipids; Prevention

Indexed keywords

CHOLESTEROL; ESTRADIOL; LEVONORGESTREL; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

EID: 0029886231     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05798-X     Document Type: Article

References (26)

1. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 1988;34:B60.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47.
3. Bush TL. Extraskeletal effects of estrogen and the prevention of atherosclerosis. Osteoporosis Int 1991;2:5.
4. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991;87:1274.
5. Haarbo J, Svendsen OL, Christiansen C. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res 1992;70:1198.
6. Adams MR, Kaplan JP, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17β estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051.
7. Kushwaha RS, Lewis DS, Carey KD, McGill HC. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.). Arterioscler Thromb 1991;11:23.
8. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-Hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation 1991;83:484.
9. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation 1987;75:1102.
10. Sullivan JM, Zwaag RV, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557.
11. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;159:312.
12. American-Canadian Co-Operative Study Group. Persantine Aspirin trial in cerebral ischemia- part III: risk factors for stroke. Stroke 1986;17:12.
13. Nachtigall MJ, Smilen SW, Nachtigall RD, Nachtigall RH, Nachtigall LE. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy. Obstet Gynecol 1992;80:827.
14. Ma PTS, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17α-ethinyl estradiol. Proc Natl Acad Sci 1986;83:792.
15. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest 1989;19:395.
16. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski MS. Post-menopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954.
17. Haarbo J, Nielsen LB, Stender S, Christiansen C. Aortic permeability to LDL during estrogen therapy. A study in normocholesterolemic rabbits. Arterioscler Thromb 1994;14:243.
18. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991;88:1995.
19. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17β-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Rad Res Comm 1990;8:167.
20. Sack MN, Rader DJ, Cannon III RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in post-menopausal women. Lancet 1994;343:269.
21. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodelling of coronary arteries in human and non-human primates. JAMA 1994;271:289.
22. E. Falk. Why do plaques rupture? Circulation 1992;86(suppl III):III-30.
23. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680.
24. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452.
25. Van Buren GA, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;167:828.
26. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993;342:133.